| Literature DB >> 29534010 |
Han Gao1, Gang Li2, Hong-Xiang Lou3,4.
Abstract
Exploration of structurally novel natural products greatly facilitates the discovery of biologically active pharmacophores that are biologically validated starting points for the development of new drugs. Endophytes that colonize the internal tissues of plant species, have been proven to produce a large number of structurally diverse secondary metabolites. These molecules exhibit remarkable biological activities, including antimicrobial, anticancer, anti-inflammatory and antiviral properties, to name but a few. This review surveys the structurally diverse natural products with new carbon skeletons, unusual ring systems, or rare structural moieties that have been isolated from endophytes between 1996 and 2016. It covers their structures and bioactivities. Biosynthesis and/or total syntheses of some important compounds are also highlighted. Some novel secondary metabolites with marked biological activities might deserve more attention from chemists and biologists in further studies.Entities:
Keywords: bioactivities; biosynthesis; endophytes; natural products; skeletons
Mesh:
Substances:
Year: 2018 PMID: 29534010 PMCID: PMC6017594 DOI: 10.3390/molecules23030646
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of divergolides A–D (1–4).
Scheme 1The proposed biosynthetic pathway for divergolides A–D (1–4), starting from the ansamycin starter unit AHBA. The polyketide backbone is proposed to be disrupted through a putative Baeyer-Villiger oxidation.
Figure 2Structures of actinoallolides A–E (5–9) and microcarpalide (10).
Figure 3Structures of blennolides A–G (11–17) and noduliprevenone (18).
Figure 4Structures of microsphaeropsones A–C (19–21), isofusidienols A–D (22–25) and lycopodiellactone (26).
Figure 5Structures of compounds 27–35.
Scheme 2Bioinspired tandem dimerization-spiroketalization for the total synthesis of pestalospirane B (31).
Figure 6Structures of (±)-torreyanic acid (36) and its analogue 37.
Figure 7Structures of compounds 38–43.
Scheme 3Biosynthesis of rubrolone B (43) on the basis of the data from feeding experiments.
Figure 8Structures of compounds 44–49.
Scheme 4Plausible biosynthetic pathway of citreoviripyrone A (46).
Figure 9Structures of citrinals A–B (50–51) and cytoskyrins A–B (52–53).
Figure 10Structures of aspertryptanthrins A–C (54–56) and spirobrocazines A–B (57–58).
Figure 11Structures of compounds 59–64.
Figure 12Structures of compounds 65–71.
Figure 13Structures of compounds 72–83.
Scheme 5(A) Proposed biosynthetic pathway for periconianone A (79); (B) Synthetic strategy to 79 inspired by the biogenetic hypothesis of 79.
Figure 14Structures of diterpenoids 84–86.
Figure 15Structures of sesterterpenoids 87–91.
Figure 16Structures of compounds 92–99.
Figure 17Structures of phomopchalasins A–B (100–101) and campyridones A–D (102–105).
Figure 18Structures of compounds 106–111.
Scheme 6Proposed biosynthetic pathway for paraphaeosphaeride A (108).
Figure 19Structures of compounds 112–116.
Figure 20Structures of pestalotiopens A–B (117–118) and peyronellins A–C (119–121).
Figure 21Structures of emericellolides A–C (122–124).
Figure 22Structures of aspergillines A–E (125–129).
Structurally novel natural products from endophytic bacteria or fungi.
| Microorganisms | Origin | Secondary Metabolites (Figures) | Reported Activities | Ref. |
|---|---|---|---|---|
| Marine, | Divergolides A–D ( | Antibacterial, cytotoxicity | [ | |
| Terrestrial, | Rubrolone B ( | NR | [ | |
| Marine, | Bacaryolanes A–C ( | NR | [ | |
| Terrestrial, | Isofusidienols A–D ( | Antibacterial | [ | |
| Terrestrial, | Spiro-mamakone A ( | Antibacterial, cytotoxicity | [ | |
| Marine | Spirobrocazines A–B ( | Antibacterial, cytotoxicity | [ | |
| Terrestrial | Chloropupukeananin ( | Antibacterial, antiviral | [ | |
| Unidentified fungus | Terrestrial, | Guanacastepene A ( | Antibacterial | [ |
| Terrestrial, | Blennolides A–G ( | Antifungal, antialgal | [ | |
| Terrestrial, | Viburspiran ( | Antifungal | [ | |
| Terrestrial, | Cryptocin ( | Antifungal | [ | |
| Terrestrial, | Cephalosol ( | Antimicrobial | [ | |
| Terrestrial, | Daldionin ( | Antimicrobial | [ | |
| Terrestrial, | Solanioic acid ( | Antimicrobial | [ | |
| Marine, alga | Harziandione ( | Antimicrobial | [ | |
| Marine | Varioxepine A ( | Antimicrobial | [ | |
| Marine, | Pestalotiopens A–B ( | Antimicrobial | [ | |
| Terrestrial | Chloropestolide A ( | Anti-HIV, cytotoxicity | [ | |
| Terrestrial, | Pericoannosin A ( | Anti-HIV | [ | |
| Marine, | Neosartoryadins A–B ( | Antiviral | [ | |
| Terrestrial, | periconiasins ( | Antiviral, cytotoxicity | [ | |
| Terrestrial, | Aspergillines A–E ( | Antiviral, cytotoxicity | [ | |
| Terrestrial, | Periconianone A ( | Anti-inflammatory | [ | |
| Unidentified fungus | Terrestrial, | Codinaeopsin ( | Antimalarial | [ |
| Terrestrial, | Phomopchalasins A–B ( | Antimigratory activity | [ | |
| Terrestrial | Apicidins A–C ( | Antiprotozoal, anticancer | [ | |
| Terrestrial, | Actinoallolides A–E ( | Anti-trypanosomal | [ | |
| Marine | Asperterpenoid A ( | Antituberculosis | [ | |
| Marine | Asperterpenols A–B ( | Acetylcholinesterase inhibition | [ | |
| Terrestrial, | Cytoskyrins A–B ( | BIA activity | [ | |
| Unidentified fungus | Terrestrial, | Microcarpalide ( | Cytotoxicity | [ |
| Marine, Alga | Noduliprevenone ( | Cytotoxicity | [ | |
| Terrestrial, | Virgatolides A–C ( | Cytotoxicity | [ | |
| Terrestrial, | (±)-torreyanic acid ( | Cytotoxicity | [ | |
| Terrestrial, | Chaetoglobins A–B ( | Cytotoxicity | [ | |
| Terrestrial, | (-)-Alternarlactam ( | Cytotoxicity | [ | |
| Terrestrial, | Duclauxamide A1 ( | Cytotoxicity | [ | |
| Terrestrial, | Citreoviripyrone A ( | Cytotoxicity | [ | |
| Terrestrial, | Chaetominine ( | Cytotoxicity | [ | |
| Terrestrial | Chloropupukeanolides A–E ( | Cytotoxicity | [ | |
| Terrestrial, | Trichoderones A–B ( | Cytotoxicity | [ | |
| Terrestrial, | Trichodermone ( | Cytotoxicity | [ | |
| Marine, | Campyridones A–D ( | Cytotoxicity | [ | |
| Marine, | Rhizovarins A–C ( | Cytotoxicity | [ | |
| Terrestrial, | Peyronellins A–C ( | Cytotoxicity | [ | |
| Terrestrial, | Pestalotiopsin A ( | Immunosuppressive | [ | |
| Terrestrial, | Penicillactones A–C ( | Inhibitors of the release of | [ | |
| Terrestrial | Phaeosphaeride A–B ( | Inhibiting STAT3 activity | [ | |
| Marine, green alga | Aspeverin ( | Marine plant growth inhibition | [ | |
| Terrestrial, | Microsphaeropsones A–C ( | NR | [ | |
| Terrestrial, | Lycopodiellactone ( | NR | [ | |
| Terrestrial, | Pestalospiranes A–B ( | NR | [ | |
| Terrestrial, | Torreyanic acid analogue ( | NR | [ | |
| Terrestrial, | Fusarimine ( | NR | [ | |
| Terrestrial, | Fusidilactone C ( | NR | [ | |
| Marine, | Coryoctalactone E ( | NR | [ | |
| Terrestrial, | Citrinals A–B ( | NR | [ | |
| Terrestrial, | Aspertryptanthrins A–C ( | NR | [ | |
| Terrestrial, | Asterogynins A–B ( | NR | [ | |
| Terrestrial, | Wortmannines A–C ( | NR | [ | |
| Terrestrial, | Secovironolide ( | NR | [ | |
| Marine, | Aspterpenacids A–B ( | NR | [ | |
| Terrestrial, | Paraphaeosphaeride A ( | NR | [ | |
| Marine, | Penibruguieramine A ( | NR | [ | |
| Terrestrial, | Emericellolides A–C ( | NR | [ |
Organize the bioactivity using alphabetical order. NR: not reported in references or have reported in literature to have no biological activities.
Figure 23Selected endophyte-derived secondary metabolites with significant biological activities.